Fitzsimons Innovation Community is proud to present a new white paper, entitled Choosing an Innovation Community, from a group of thought leaders in the Colorado bioscience and economic development communities. This extensive report looks at the factors that go into choosing the right innovation community for life sciences companies of all sizes. Whether you’re looking to put down roots in Colorado or at one of the other innovation communities across the country, this white paper helps you navigate the process with a focus on what means the most to you and your organization.
Find out what's happening on campus and across the industry.
Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.
The past several years culminated into one of the most secure and vigorous periods for capital investment access, and Colorado life sciences companies were able to take full advantage. The Colorado life sciences industry has consistently raised more than a billion investment dollars annually for the past six years, topping $2 billion in 2021. (CBSA) From state grants to larger venture investments, the Colorado healthcare innovation ecosystem has been well-funded and poised for breakthroughs, and Fitzsimons Innovation Community is proud to be the home of many members of that ecosystem.
Ideas become cures when academia and industry connect. When you talk to Terry Fry, M.D., about why the Gates Institute is one of the best locations in the country to work in cellular and gene therapy, he has a lot of insight. As the executive director of the Gates Institute, a pediatric oncologist, and a pioneer in the development of chimeric antigen receptor (CAR)-T cell therapies, Dr. Fry has an intimate understanding of what it takes to get a drug from initial research phases to commercial manufacturing. And often what it takes is the right facilities with the right partners working together at each stage of development.